TrialSpark logo

TrialSpark Funding & Investors

New York, NY

TrialSpark is a technology-driven pharma company that runs end-to-end clinical trials, focused on bringing new treatments to patients faster and more efficiently. TrialSpark has built a technology platform that optimizes all aspects of a clinical trial, enabling more efficient trial design, faster trial completion, and higher trial data quality. TrialSpark in-licenses and co-develops drug programs through in-house development, joint ventures, and NewCos.

https://www.trialspark.com/

Total Amount Raised: $156,000,000

TrialSpark Funding Rounds

  • Series C

    $156,000,000

    Series C Investors

    Lachy Groom
    Sam Altman
    Section 32
    Sound Ventures
    Sequoia Capital
    Thrive Capital
    Spark Capital
    Casdin Capital
    Dragoneer Investment Group
    Felicis
    John Doerr
    ArrowMark Partners
    Hyphen Capital
Funding info provided by Diffbot.